DRUG · Mapped RxNorm record
Atezolizumab
Normalized identity: atezolizumabView linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
First Line Atezolizumab, Paclitaxel, and Bevacizumab (Avastin®) in mTNBC
NCT04408118
Drugs and interventions used in this trial
3 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Mapped RxNorm record
Paclitaxel
Normalized identity: paclitaxelView linked drug · Find medicine records ·
Find other trials using this name
DRUG · Mapped RxNorm record
Bevacizumab
Normalized identity: bevacizumabView linked drug · Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedFirst Line Atezolizumab, Paclitaxel, and Bevacizumab (Avastin®) in mTNBC
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Metastatic Breast Cancerunresolved
Advanced Breast Cancerunresolved
Triple Negative Breast Cancerunresolved
Interventions
AtezolizumabDRUG · verified · RxNorm: atezolizumab
PaclitaxelDRUG · verified · RxNorm: paclitaxel
BevacizumabDRUG · verified · RxNorm: bevacizumab
Sponsors & collaborators
MedSIRlead sponsor
Hoffmann-La Rochecollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT04408118 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.